Health Trials

Nash Non Alcoholic Steatohepatitis

2

Review clinical trials related to Nash Non Alcoholic Steatohepatitis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

A phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and tolerability of HSK31679 compared to placebo in patients with metabolic dysfunction-associated steatohepatitis (MASH) .

Participants needed: 400
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Haisco Pharmaceutical Group Co., Ltd.Updated: Jun 17, 2026
Eligibility criteria

1. Must be willing to participate in the study and provide written informed cons... [+5]

1. History of significant alcohol consumption for a period of more than 3 consec... [+7]

Read more
Status: Recruiting

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

The objective of the study is to evaluate an ultraportable ultrasound device, Hepatoscope, for the non-invasive assessment of hepatic steatosis in patients with metabolic-dysfunction associated liver diseases (MASLD), by comparing its measurements with current diagnostic modalities, such as MRI-PDFF.

Participants needed: 120
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: E-ScopicsUpdated: Aug 15, 2025Locations: 3
Eligibility criteria

Adult patient below 80 yo [+5]

Patient in their minority (less than 18 yo) or older than 80 yo, [+9]

Read more